Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Sitared-M Tablet 50/500

Prescription Icon
Prescription Required

Marketer

Sun Pharmaceutical Industries Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitared-M Tablet 50/500

Diabex Duo 50/500mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent severe diabetic complications like vision impairment and kidney disease, potentially lowering the risk of cardiovascular events like stroke and heart attack. Diabex Duo 50/500mg may be used as a standalone treatment or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, blood sugar readings, and other concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. For maximum effectiveness, adhere to a consistent daily dosing schedule; discontinuation should only occur under medical supervision. Maintaining the prescribed diet and exercise plan is crucial for effective diabetes management; lifestyle choices significantly impact disease control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and sore throat. Hypoglycemia is a potential risk, particularly when combined with insulin or sulfonylureas; learn to recognize and manage this complication. This medication isn't appropriate for everyone. Consult your physician before starting Diabex Duo 50/500mg if you have a history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical advice. Inform your doctor about all other medications you're taking, as interactions are possible. Alcohol should be minimized due to its blood glucose-lowering effect. Your doctor will monitor your kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Sitared-M Tablet 50/500

No text provided. Please provide the text you would like me to rephrase.

Uses of Sitared-M Tablet 50/500

Managing type 2 diabetes

Major Benefits of Sitared-M Tablet 50/500:

Consume Sitared-M 50/500 tablets as directed by your physician, adhering precisely to the prescribed dosage and treatment length. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Take this medication with food.

Common Side effects of Sitared-M Tablet 50/500:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitared-M Tablet 50/500:

Consume Sitared-M 50/500 tablets as directed by your physician, adhering precisely to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take this medication with food.

How Sitared-M Tablet 50/500 works:

Sitared-M 50/500mg tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Sitared-M 50/500 tablets and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitared-M 50/500 tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Sitared-M 50/500 tablets are likely incompatible. Available data from human studies indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitared-M 50/500 tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitared-M 50/500 use. Consult your physician. Routine kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Sitared-M 50/500 tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitared-M Tablet 50/500 :

Should you forget a dose of Sitared-M 50/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitared-M Tablet 50/500

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitared-M Tablet 50/500

Sitared-M 50/500 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitared-M Tablet 50/500 use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Sitared-M 50/500mg tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitared-M 50/500 should not be used by individuals with allergies to its ingredients or fillers. This medication is also contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitared-M 50/500 with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin 50/500 (like Sitared-M) can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this risk is higher in patients with kidney disease, older adults, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Sitared-M 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitared-M 50/500mg tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitared-M 50/500 should not be used by patients allergic to its ingredients or fillers. Its use is also contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol with Sitared-M 50/500 is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this risk is higher in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Prolonged Sitared-M Tablet 50/500 use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitared-M 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitared-M 50/500 mg tablets may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitared-M 50/500 tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitared-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitared-M 50/500) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitared-M Tablet 50/500 use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), and urinary issues, potentially altering mental status. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitared-M Tablet 50/500
147
MRP 171
14% off